|
|
|
|
|
|
|
SELLAS Life Sciences Group Inc. (SLS)
|
|
1.68 -0.27 (-13.85%)
|
11-15 16:00
|
|
Open:
|
1.82
|
Pre. Close:
|
1.95
|
|
High:
|
1.82
|
Low:
|
1.65
|
|
Volume:
|
1,243,396
|
Market Cap:
|
33M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.824 - 1.833
|
1.833 - 1.841
|
|
Low:
|
1.627 - 1.638
|
1.638 - 1.647
|
|
Close:
|
1.664 - 1.681
|
1.681 - 1.695
|
|
|
|
Technical analysis (as of: 2018-11-15 4:35:05 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 2.27 One year: 2.87
|
|
Support:
|
Support1: 1.10 Support2: 0.92
|
|
Resistance:
|
Resistance1:
1.94 Resistance2: 2.46
|
|
Pivot:
|
1.66 
|
|
Moving Averages:
|
MA(5): 1.89 MA(20): 1.60
MA(100): 1.50 MA(250): 4.33
|
|
MACD:
|
MACD(12,26):
0.14 Signal(12,26,9): 0.12
|
|
%K %D:
|
%K(14,3): 55.39 %D(3): 60.87
|
|
RSI:
|
RSI(14): 51.76
|
|
52-Week:
|
High: 12
Low: 0.8 Change(%): -81.3
|
|
Average Vol(K):
|
3-Month: 213266
10-Days 272851
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.SLS has closed below upper band by 48.6%. Bollinger Bands are 4.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-11-15T12:46:00-05:00
SELLAS Life Sciences Group, Inc. (SLS) CEO Angelos Stergiou on Q3 2018 Results - Earnings Call Transcript
2018-11-15T09:18:05-05:00
RBS, LYG and BCS among premarket losers
2018-11-15T08:34:45-05:00
SELLAS Life Sciences down 3% on Q3 result
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
